AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Primary Health Properties PLC

Major Shareholding Notification Feb 13, 2019

4780_rns_2019-02-13_d4592530-9724-4d4d-a46c-fc7fcf4f86b2.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9119P

Citadel Group

13 February 2019

FORM 8 AMENDMENT

The Form 8.3 - Citadel Group announcement released on 12 February 2019 at under RNS No 7659P has been amended.

Amendments are identified with an asterisk (*).

The full amended text is shown below.

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%

OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Citadel Group
(b) Owner or controller of interests and short positions        

     disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is

     insufficient.  For a trust, the trustee(s), settlor and

     beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant

     securities this form relates:

     Use a separate form for each offeror/offeree
PRIMARY HEALTH PROPERTIES PLC
(d) If an exempt fund manager connected with an

     offeror/offeree, state this and specify identity of

     offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest

practicable date prior to the disclosure
11 February, 2019
(f)  In addition to the company in 1(c) above, is the

     discloser making disclosures in respect of any other

     party to the offer?

If it is a cash offer or possible cash offer, state "N/A"
MEDICX FUND LTD

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Convertible Bond  ISIN  XS1067950615
Interests Short Positions
Number % Number %
(1) Relevant securities owned and/or controlled: 3,000,000 20.68 0 0.00
(2) Cash-settled derivatives: 0 0.00 0 0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0.00 0 0.00
TOTAL: 3,000,000 20.68 0 0.00
Class of relevant security: Common Stock  ISIN  GB00BYRJ5J14
Interests Short Positions
Number % Number %
(1) Relevant securities owned and/or controlled: 0 0.00 29,428 0.00
(2) Cash-settled derivatives: 0 0.00 3,303,094 0.42
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0.00 0 0.00
TOTAL: 0 0.00 3,332,522 0.43

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

*

Class of relevant security

ISIN  XS1067950615
Purchase/sale Number of securities Price per unit
Convertible Bond Sale -1,700,000 120.5  GBP
Class of relevant security

ISIN  GB00BYRJ5J14
Purchase/sale Number of securities Price per unit
Common Stock Purchase 19,025 1.16  GBP
Common Stock Purchase 12,688 1.162  GBP
Common Stock Purchase 14,189 1.164  GBP
Common Stock Purchase 5,261 1.166  GBP
Common Stock Purchase 4,713 1.168  GBP
Common Stock Purchase 56 1.17  GBP
Common Stock Purchase 3,434 1.172  GBP
Common Stock Purchase 7,218 1.176  GBP
Common Stock Sale -7,732 1.16  GBP
Common Stock Sale -22,386 1.162  GBP
Common Stock Sale -17,137 1.164  GBP
Common Stock Sale -18,428 1.166  GBP
Common Stock Sale -20,220 1.168  GBP
Common Stock Sale -643 1.17  GBP
Common Stock Sale -2,000 1.172  GBP
Common Stock Sale -1,460 1.174  GBP
Common Stock Sale -10,638 1.176  GBP
Common Stock Sale -1,569 1.178  GBP

(b)        Cash-settled derivative transactions

Class of relevant security

ISIN  GB00BYRJ5J14
Product description

e.g. CFD
Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
Common Stock CFD Increasing short position -165,356 1.166702  GBP
Common Stock CFD Increasing short position -10,300 1.16761  GBP
Common Stock CFD Increasing short position -58,926 1.167611  GBP
Common Stock CFD Reducing long position -2,319 1.16761  GBP
Common Stock CFD Reducing long position -1,731 1.16761  GBP
Common Stock CFD Reducing long position -70 1.16761  GBP
Common Stock CFD Reducing long position -29 1.16761  GBP
Common Stock CFD Reducing long position -24 1.16761  GBP
Common Stock CFD Reducing long position -2 1.16761  GBP
Common Stock CFD Reducing short position 6,870 1.170934  GBP
Common Stock CFD Reducing short position 196 1.172  GBP
Common Stock CFD Reducing short position 1,059 1.172  GBP
Common Stock CFD Reducing short position 1,156 1.172  GBP
Common Stock CFD Reducing short position 10,592 1.172  GBP
Common Stock CFD Reducing short position 11,564 1.172  GBP
Common Stock CFD Reducing short position 22,205 1.172  GBP
Common Stock CFD Reducing short position 22,325 1.172  GBP
Common Stock CFD Reducing short position 40,000 1.172  GBP
Common Stock CFD Reducing short position 41,756 1.172  GBP
Common Stock CFD Reducing short position 64,302 1.172  GBP
Common Stock CFD Reducing short position 262,140 1.172  GBP
Common Stock CFD Reducing short position 1,290,592 1.172  GBP

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(ii)        Exercise

Class of relevant security Product description

e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion
Details Price per unit (if applicable)

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
None
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"
None
None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 12 February, 2019
Contact name: Jamison Van Doesburg
Telephone number*: 020 7645 9700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RETSFFFFDFUSESE

Talk to a Data Expert

Have a question? We'll get back to you promptly.